EDIT

NASDAQ · Biotechnology

Editas Medicine Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$2.51

-0.07 (-2.71%)

As of Sep 28, 10:16 PM ET ·

EDIT News1 articles

CRISPR Therapeutics Surges 12% on Gene-Editing Sector Rally

CRISPR Therapeutics shares surged 12% in New York trading, buoyed by a sector-wide gene-editing rally and Eli Lilly's $1.9 billion deal with Ascidian Therapeutics.